FRANKFURT, Nov 21 (Reuters) - The European Patent Office declared a contested mRNA patent owned by Moderna (MRNA.O) invalid, the office said on Tuesday, handing a win to BioNTech (22UAy.DE) and its
in 2022 that Eolas' patent was invalid, and the U.S. Court of Appeals for the Federal Circuit affirmed the decision in February, determining that the patent was directed to the abstract concept of
The US Court of Appeals for the Federal Circuit has affirmed the invalidation of a number of claims in a patent owned by telecommunications conglomerate AT&T. The court found that the patent, US
A Patent Trial and Appeal Board (PTAB) ruling that an IBM patent was invalid has been reversed by the US Court of Appeals for the Federal Circuit. IBM’s US patent (7,631,346) covered a method and
Property Administration (CNIPA) issued Invalidation Decision No. 26414 on June 26, 2015, finding that claims 1-5 lacked inventiveness and declaring the entire patent invalid. Dissatisfied with this
Property Administration (CNIPA) issued Invalidation Decision No. 26414 on June 26, 2015, finding that claims 1-5 lacked inventiveness and declaring the entire patent invalid. Dissatisfied with this